查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1703333

人體類器官市場－全球產業規模、佔有率、趨勢、機會及預測（依來源、器官類型、地區及競爭格局分類，2020-2030 年預測）

Human Organoids Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Source, By Organ Type, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球人類類器官市場價值為 5.1024 億美元，預計到 2030 年將達到 6.4379 億美元，預測期內複合年成長率為 4.15%。全球人類類器官市場正在經歷顯著成長，這得益於生物技術的進步、個人化醫療需求的不斷成長以及專注於疾病建模和藥物發現的研究活動的增加。類器官是由幹細胞培育出的人體器官的3D微型版本，與傳統方法相比，它為以更精確、更符合倫理道德的永續方式研究人體生物學提供了一個創新平台。這個市場在製藥、生物技術和學術領域越來越受到關注，為研究、藥物測試和再生醫學提供了一個有希望的途徑。

市場概覽
預測期 2026-2030
2024年市場規模 5.1024億美元
2030年市場規模 6.4379億美元
2025-2030 年複合年成長率 4.15%
成長最快的領域 成體幹細胞
最大的市場 北美洲

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

開發和研究成本高

主要市場趨勢

藥物研發與檢驗領域應用日益增多

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球人體類器官市場的影響

第5章：全球人類類器官市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依來源（成體幹細胞、誘導性多能幹細胞、胚胎幹細胞、其他）
    • 依器官類型（胃模型、腸模型、肝臟模型、胰臟模型、肺部模型、腦部模型、腎臟模型、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美人體類器官市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲人體類器官市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區人類類器官市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲人體類器官市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲人類類器官市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：全球人類類器官市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

    • 美國典型培養物保藏中心（ATCC）
    • 業務概覽
    • 公司概況
    • 產品與服務
    • 財務狀況（據報告）
    • 最新動態
    • 主要人員詳情
    • SWOT分析
  • 賽默飛世爾科技公司
  • 加拿大幹細胞技術公司
  • 默克公司
  • 康寧公司
  • 生技公司
  • ACROBIOSYSTEMS公司
  • AMS生物技術（歐洲）有限公司
  • Qkine有限公司
  • PRIMACYT 細胞培養技術有限公司

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 28070

Global Human Organoids Market was valued at USD 510.24 Million in 2024 and is expected to reach USD 643.79 Million by 2030 with a CAGR of 4.15% during the forecast period. The global human organoids market is witnessing significant growth, driven by advancements in biotechnology, increasing demand for personalized medicine, and a rise in research activities focusing on disease modeling and drug discovery. Organoids, which are three-dimensional, miniature versions of human organs grown from stem cells, offer an innovative platform for studying human biology in a more precise and ethically sustainable way compared to traditional methods. This market is gaining traction across pharmaceutical, biotechnology, and academic sectors, offering promising avenues for research, drug testing, and regenerative medicine.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 510.24 Million
Market Size 2030USD 643.79 Million
CAGR 2025-20304.15%
Fastest Growing SegmentAdult Stem Cells
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The growth of the global healthcare industry is a key driver of the human organoids market, propelling advancements in research, personalized medicine, and drug development. The healthcare industry ranks among the largest and most rapidly expanding sectors globally. In many developed countries, healthcare expenditures exceed 10 percent of the gross domestic product (GDP), representing a substantial portion of their economies. In the United States, healthcare spending increased by 2.7 percent in 2021, totaling USD 4.3 trillion, or USD 12,914 per capita. Healthcare spending also accounted for 18.3 percent of the nation's GDP. As healthcare systems worldwide continue to expand and evolve, there is a growing emphasis on innovative solutions to enhance the understanding of human biology, improve disease modeling, and accelerate the development of novel therapeutics. Human organoids-3D structures grown from stem cells that mimic the architecture and functionality of human organs-are becoming a critical tool in these advancements.

Key Market Challenges

High Costs of Development and Research

One of the key challenges facing the global human organoids market is the high costs associated with the development and research of these advanced biological models. The process of creating organoids, which involves cultivating stem cells to mimic the structure and function of human organs, requires cutting-edge technology, specialized expertise, and extensive laboratory resources. These factors contribute to significant upfront investment and ongoing operational expenses, which can hinder the widespread adoption and scalability of organoid technology.

The development of human organoids requires sophisticated equipment such as bioreactors, 3D cell culture systems, and precise imaging technologies, all of which are expensive to acquire and maintain. In addition, the cultivation of high-quality stem cells and the optimization of growth conditions to produce functional organoids are complex tasks that demand highly skilled personnel. Hiring and training researchers with the expertise to work with these intricate models further adds to the cost burden.

Key Market Trends

Rising Applications in Drug Discovery and Testing

The rising applications of human organoids in drug discovery and testing are emerging as a significant trend in the global human organoids market, transforming the way pharmaceutical research is conducted. Human organoids, which are lab-grown 3D structures that mimic the physiological and functional properties of human organs, offer a highly accurate platform for studying human diseases, testing new drugs, and predicting treatment outcomes. This innovative technology is gaining widespread adoption in the pharmaceutical industry, driven by the need for more efficient, cost-effective, and reliable drug development processes. In 2020, 53 new medicines were introduced, and over 9,000 compounds are currently in various stages of development worldwide. The research-driven biopharmaceutical sector is estimated to have invested USD 198 billion globally in R&D during that year.

Key Market Players

  • American Type Culture Collection (ATCC)
  • Thermo Fisher Scientific Inc.
  • STEMCELL Technologies Canada Inc.
  • Merck KGaA
  • Corning Incorporated
  • Bio-Techne Corporation
  • ACROBIOSYSTEMS INC.
  • AMS Biotechnology (Europe) Ltd
  • Qkine Ltd.
  • PRIMACYT Cell Culture Technology GmbH

Report Scope

In this report, the Global Human Organoids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Human Organoids Market, By Source:

  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • Others

Human Organoids Market, By Organ Type:

  • Stomach Models
  • Intestine Models
  • Liver Models
  • Pancreatic Models
  • Lung Models
  • Brain Models
  • Kidney Models
  • Others

Human Organoids Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Human Organoids Market.

Available Customizations:

Global Human Organoids Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Human Organoids Market

5. Global Human Organoids Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others)
    • 5.2.2. By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Human Organoids Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Organ Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Human Organoids Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Source
        • 6.3.1.2.2. By Organ Type
    • 6.3.2. Mexico Human Organoids Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Source
        • 6.3.2.2.2. By Organ Type
    • 6.3.3. Canada Human Organoids Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Source
        • 6.3.3.2.2. By Organ Type

7. Europe Human Organoids Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Organ Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Human Organoids Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Source
        • 7.3.1.2.2. By Organ Type
    • 7.3.2. Germany Human Organoids Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Source
        • 7.3.2.2.2. By Organ Type
    • 7.3.3. United Kingdom Human Organoids Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Source
        • 7.3.3.2.2. By Organ Type
    • 7.3.4. Italy Human Organoids Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Source
        • 7.3.4.2.2. By Organ Type
    • 7.3.5. Spain Human Organoids Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Source
        • 7.3.5.2.2. By Organ Type

8. Asia Pacific Human Organoids Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Organ Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Human Organoids Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Source
        • 8.3.1.2.2. By Organ Type
    • 8.3.2. India Human Organoids Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Source
        • 8.3.2.2.2. By Organ Type
    • 8.3.3. South Korea Human Organoids Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Source
        • 8.3.3.2.2. By Organ Type
    • 8.3.4. Japan Human Organoids Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Source
        • 8.3.4.2.2. By Organ Type
    • 8.3.5. Australia Human Organoids Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Source
        • 8.3.5.2.2. By Organ Type

9. South America Human Organoids Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Organ Type
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Human Organoids Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Source
        • 9.3.1.2.2. By Organ Type
    • 9.3.2. Argentina Human Organoids Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Source
        • 9.3.2.2.2. By Organ Type
    • 9.3.3. Colombia Human Organoids Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Source
        • 9.3.3.2.2. By Organ Type

10. Middle East and Africa Human Organoids Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Organ Type
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Human Organoids Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Source
        • 10.3.1.2.2. By Organ Type
    • 10.3.2. Saudi Arabia Human Organoids Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Source
        • 10.3.2.2.2. By Organ Type
    • 10.3.3. UAE Human Organoids Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Source
        • 10.3.3.2.2. By Organ Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Human Organoids Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

    • 15.1.1. American Type Culture Collection (ATCC)
    • 15.1.2. Business Overview
    • 15.1.3. Company Snapshot
    • 15.1.4. Products & Services
    • 15.1.5. Financials (As Reported)
    • 15.1.6. Recent Developments
    • 15.1.7. Key Personnel Details
    • 15.1.8. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. STEMCELL Technologies Canada Inc.
  • 15.4. Merck KGaA
  • 15.5. Corning Incorporated
  • 15.6. Bio-Techne Corporation
  • 15.7. ACROBIOSYSTEMS INC.
  • 15.8. AMS Biotechnology (Europe) Ltd
  • 15.9. Qkine Ltd.
  • 15.10. PRIMACYT Cell Culture Technology GmbH

16. Strategic Recommendations

17. About Us & Disclaimer